Citation Impact
67 standout
Citing Papers
[177Lu]Lu-DOTA-TATE plus long-acting octreotide versus high‑dose long-acting octreotide for the treatment of newly diagnosed, advanced grade 2–3, well-differentiated, gastroenteropancreatic neuroendocrine tumours (NETTER-2): an open-label, randomised, phase 3 study
2024 Standout
Thyroid Cancer
2024 Standout
Works of L. Somma being referenced
Clinical efficacy of octreotide in the treatment of metastatic neuroendocrine tumors: A study by the Italian Trials in Medical Oncology group
1996
A phase II trial of dacarbazine, fluorouracil and epirubicin in patients with neuroendocrine tumours. A study by the Italian Trials in Medical Oncology (I.T.M.O.) Group
1995
Author Peers
| Author | Oncology | PRM | Neurology | Epidemiology | Last Decade | Papers | Cites |
|---|---|---|---|---|---|---|---|
| L. Somma | 359 | 44 | 202 | 252 | 10 | 403 | |
| Sultana S. Zaman | 1 | 16 | 1 | 22 | 14 | 632 | |
| A. J. Hale | 16 | 483 | |||||
| Naomi Miyaji | 22 | 274 | |||||
| GaryF. Bennett | 5 | 13 | 2 | 8 | 24 | 672 |
All Works
Loading papers...